FRI-462-A multicenter international study of sorafenib treatment in patients with hepatocellular carcinoma and chronic kidney disease undergoing hemodialysis

Authors :: Alvaro Diaz-Gonzalez
Marco Sanduzzi-Zamparelli
Leonardo Gomes da Fonseca
Giovan Giuseppe Di Costanzo
Rogério Alves
Massimo Iavarone
Cassia Regina G Leal
Rodolfo Sacco
Ana M Matilla
Manuel Hernández Guerra
Gabriel Alejandro Aballay Soteras
Worns Marcus
Matthias Pinter
Maria Varela
Morten Ladekarl
Aline Lopes Chagas
Beatriz Minguez
Juan Ignacio
Arenas Ruiz-Tapiador
Alessandro Granito
Yolanda Sánchez
Angela Rojas
Carlos Rodriguez De Lope
Mario Reis Álvares-Da-Silva
Sonia Pascual
Lorenza Rimassa
José Luis Lledó
Carlos Huertas
Bruno Sangro
Edoardo Giovanni Giannini
Manuel Delgado
Mercedes Vergara Gómez
Christie Perello
Alberto Lué
Margarita Sala
Adolfo Gallego Moya
Susana Coll
Tania Hernaez Alsina
Federico Pinero
Gustavo Pereira
Alex Vianey Callado França
Juan Marín
Maria Margarita Anders
Vivianne Mello
María Del Mar Lozano
Jean Charles Nault
José María Menéndez
Ignacio Garcia Juarez
Jordi Bruix
Maria Reig
Source :: Journal of Hepatology. 70:e599-e600
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Sorafenib
medicine.medical_specialty
Hepatology
business.industry
medicine.medical_treatment
Sorafenib treatment
medicine.disease
Gastroenterology
Hepatocellular carcinoma
Internal medicine
medicine
In patient
Hemodialysis
business
Kidney disease
medicine.drug

Full Text Access

Tools